Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines
- 30 November 2009
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 84 (2), 101-118
- https://doi.org/10.1016/j.antiviral.2009.08.002
Abstract
No abstract availableKeywords
This publication has 203 references indexed in Scilit:
- TFIIH Transcription Factor, a Target for the Rift Valley Hemorrhagic Fever VirusCell, 2004
- Rift Valley Fever Epidemic in Saudi Arabia: Epidemiological, Clinical, and Laboratory CharacteristicsClinical Infectious Diseases, 2003
- Vector Competence of Selected North American Culex and Coquillettidia Mosquitoes for West Nile VirusEmerging Infectious Diseases, 2001
- Reverse Genetics System for Uukuniemi Virus ( Bunyaviridae ): RNA Polymerase I-Catalyzed Expression of Chimeric Viral RNAsJournal of Virology, 2001
- Rift valley fever on the east coast of MadagascarResearch in Virology, 1991
- Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trialsVaccine, 1986
- Lassa FeverNew England Journal of Medicine, 1986
- Mutagen-directed Attenuation of Rift Valley Fever Virus as a Method for Vaccine DevelopmentJournal of General Virology, 1985
- Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humansVaccine, 1985
- A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injectionVaccine, 1985